Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Malignant insulinoma: Recommendations for characterisation and treatment
Éric Baudin, Philippe Caron, Catherine Lombard‐Bohas, et al.
Annales d Endocrinologie (2013) Vol. 74, Iss. 5-6, pp. 523-533
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
Massimo Falconi, Barbro Eriksson, Gregory Kaltsas, et al.
Neuroendocrinology (2016) Vol. 103, Iss. 2, pp. 153-171
Open Access | Times Cited: 1236
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
Þorvarður R. Hálfdánarson, Jonathan Strosberg, Laura Tang, et al.
Pancreas (2020) Vol. 49, Iss. 7, pp. 863-881
Closed Access | Times Cited: 138
Hyperinsulinaemic hypoglycaemia in children and adults
Pratik Shah, Sofia Rahman, Hüseyin Demirbilek, et al.
The Lancet Diabetes & Endocrinology (2016) Vol. 5, Iss. 9, pp. 729-742
Closed Access | Times Cited: 116
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
Louis de Mestier, Côme Lepage, Éric Baudin, et al.
Digestive and Liver Disease (2020) Vol. 52, Iss. 5, pp. 473-492
Closed Access | Times Cited: 114
Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies
Tetsuhide Ito, Lingaku Lee, Robert T. Jensen
Expert Opinion on Pharmacotherapy (2016) Vol. 17, Iss. 16, pp. 2191-2205
Open Access | Times Cited: 86
Approach to the Patient: Insulinoma
Johannes Hofland, Julie Refardt, Richard A. Feelders, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 4, pp. 1109-1118
Open Access | Times Cited: 24
Management of functional neuroendocrine tumors of the pancreas
Kjell Öberg
Gland Surgery (2018) Vol. 7, Iss. 1, pp. 20-27
Open Access | Times Cited: 74
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
Aura D. Herrera‐Martínez, Johannes Hofland, Leo J. Hofland, et al.
Drugs (2018) Vol. 79, Iss. 1, pp. 21-42
Open Access | Times Cited: 66
The treatment of hyperinsulinemic hypoglycaemia in adults: an update
Maria Vittoria Davì, A. Pia, Valentina Guarnotta, et al.
Journal of Endocrinological Investigation (2016) Vol. 40, Iss. 1, pp. 9-20
Open Access | Times Cited: 50
Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
Liene Friebe, Martin T. Freitag, Martin Braun, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 2, pp. 228-235
Open Access | Times Cited: 14
Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors
A.B. Câmara-de-Souza, Marcos Tadashi Kakitani Toyoshima, Maria Lúcia Corrêa‐Giannella, et al.
Pancreatology (2018) Vol. 18, Iss. 3, pp. 298-303
Closed Access | Times Cited: 46
Glycemic control in patients with insulinoma
Agata Matej, Hanna Bujwid, Jakub Wroński
HORMONES (2017) Vol. 15, Iss. 4, pp. 489-499
Open Access | Times Cited: 41
Comparison of benign and malignant insulinoma
Alaa Sada, Thomas Szabo Yamashita, Amy E. Glasgow, et al.
The American Journal of Surgery (2020) Vol. 221, Iss. 2, pp. 437-447
Closed Access | Times Cited: 36
Malignant Insulinoma: A Rare Form of Neuroendocrine Tumor
Alaa Sada, Amy E. Glasgow, Adrian Vella, et al.
World Journal of Surgery (2020) Vol. 44, Iss. 7, pp. 2288-2294
Open Access | Times Cited: 33
Continuous glucose monitoring in the ruling out recurrent insulinoma
M. Yu. Yukina, Е. А. Трошина, Nurana Nuralieva, et al.
Endocrine Surgery (2025) Vol. 18, Iss. 4, pp. 25-32
Open Access
Clinical Management of Malignant Insulinoma: a single Institution’s experience over three decades
Jie Yu, Fan Ping, Huabing Zhang, et al.
BMC Endocrine Disorders (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 28
Surgical Management of Neuroendocrine Tumours of the Pancreas
Régis Souche, Christian Hobeika, Élisabeth Hain, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2993-2993
Open Access | Times Cited: 25
Surgical management of pancreatic neuroendocrine tumors: an introduction
Élisabeth Hain, Rémy Sindayigaya, Jade Fawaz, et al.
Expert Review of Anticancer Therapy (2019) Vol. 19, Iss. 12, pp. 1089-1100
Closed Access | Times Cited: 23
A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series
Run Yu, Nicholas N. Nissen, Andrew Hendifar, et al.
Pancreas (2016) Vol. 46, Iss. 1, pp. 48-56
Closed Access | Times Cited: 23
The incidence of insulinoma in Western Sweden between 2002 and 2019
Ellinor Svensson
Annals of Gastroenterology (2022)
Open Access | Times Cited: 12
Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature
Sandrine Oziel-Taïeb, Jemima Maniry-Quellier, Brice Chanez, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
Franco Grimaldi, Nicola Fazio, Roberto Attanasio, et al.
Journal of Endocrinological Investigation (2014) Vol. 37, Iss. 9, pp. 875-909
Open Access | Times Cited: 21
Nowotwory neuroendokrynne trzustki — zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)
Beata Kos‐Kudła, Violetta Rosiek, Małgorzata Borowska, et al.
Endokrynologia Polska (2017) Vol. 68, Iss. 2, pp. 169-197
Open Access | Times Cited: 20
Insulinoma: Metastatic Recurrence 38 Years Following Initial Diagnosis in Pregnancy
C. Preston, Nirupa Sachithanandan, Ie‐Wen Sim, et al.
JCEM Case Reports (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 1
Giant insulinoma: report of a case and review of published reports
Kazumitsu Ueda, Tetsuro Taira, Hiroyuki Hakoda, et al.
Surgical Case Reports (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top